BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12499914)

  • 1. Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians.
    Pernick NL; Sarkar FH; Philip PA; Arlauskas P; Shields AF; Vaitkevicius VK; Dugan MC; Adsay NV
    Pancreas; 2003 Jan; 26(1):28-32. PubMed ID: 12499914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas and Fas ligand expression in pancreatic adenocarcinoma.
    Pernick NL; Sarkar FH; Tabaczka P; Kotcher G; Frank J; Adsay NV
    Pancreas; 2002 Oct; 25(3):e36-41. PubMed ID: 12370548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.
    Katkoori VR; Jia X; Shanmugam C; Wan W; Meleth S; Bumpers H; Grizzle WE; Manne U
    Clin Cancer Res; 2009 Apr; 15(7):2406-16. PubMed ID: 19339276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups.
    Chang KJ; Parasher G; Christie C; Largent J; Anton-Culver H
    Cancer; 2005 Jan; 103(2):349-57. PubMed ID: 15593353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.
    Kawesha A; Ghaneh P; Andrén-Sandberg A; Ograed D; Skar R; Dawiskiba S; Evans JD; Campbell F; Lemoine N; Neoptolemos JP
    Int J Cancer; 2000 Nov; 89(6):469-74. PubMed ID: 11102889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.
    Dignam JJ
    J Natl Cancer Inst Monogr; 2001; (30):36-43. PubMed ID: 11773290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care.
    Pamboukian SV; Costanzo MR; Meyer P; Bartlett L; McLeod M; Heroux A
    J Card Fail; 2003 Apr; 9(2):80-6. PubMed ID: 12751127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.
    Zell JA; Rhee JM; Ziogas A; Lipkin SM; Anton-Culver H
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):546-52. PubMed ID: 17372250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience.
    Takai S; Satoi S; Toyokawa H; Yanagimoto H; Sugimoto N; Tsuji K; Araki H; Matsui Y; Imamura A; Kwon AH; Kamiyama Y
    Pancreas; 2003 Apr; 26(3):243-9. PubMed ID: 12657950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.
    McCollum AD; Catalano PJ; Haller DG; Mayer RJ; Macdonald JS; Benson AB; Fuchs CS
    J Natl Cancer Inst; 2002 Aug; 94(15):1160-7. PubMed ID: 12165641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients.
    Soliman AS; Bondy M; Webb CR; Schottenfeld D; Bonner J; El-Ghawalby N; Soultan A; Abdel-Wahab M; Fathy O; Ebidi G; Zhang Q; Greenson JK; Abbruzzese JL; Hamilton SR
    Int J Cancer; 2006 Sep; 119(6):1455-61. PubMed ID: 16619252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
    Dergham ST; Dugan MC; Kucway R; Du W; Kamarauskiene DS; Vaitkevicius VK; Crissman JD; Sarkar FH
    Int J Pancreatol; 1997 Apr; 21(2):127-43. PubMed ID: 9209954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
    Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
    Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases.
    Basturk O; Adsay V; Askan G; Dhall D; Zamboni G; Shimizu M; Cymes K; Carneiro F; Balci S; Sigel C; Reid MD; Esposito I; Baldaia H; Allen P; Klöppel G; Klimstra DS
    Am J Surg Pathol; 2017 Mar; 41(3):313-325. PubMed ID: 27984235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution.
    Sylvester BE; Huo D; Khramtsov A; Zhang J; Smalling RV; Olugbile S; Polite BN; Olopade OI
    Clin Cancer Res; 2012 Jan; 18(2):350-9. PubMed ID: 22114137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
    Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
    Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes.
    Riner AN; Underwood PW; Yang K; Herremans KM; Cameron ME; Chamala S; Qiu P; George TJ; Permuth JB; Merchant NB; Trevino JG
    Cancer Med; 2020 Jun; 9(12):4069-4082. PubMed ID: 32285629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients.
    Shin SH; Kim SC; Song KB; Hwang DW; Lee JH; Park KM; Lee YJ
    Surgery; 2018 Sep; 164(3):432-442. PubMed ID: 29884479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.